EXCLUSIVE: Strategies And Insights For Sustainable Success From 4 Cannabis Industry Leaders
What makes a cannabis brand survive, grow and eventually become a favorite among consumers?
This Online Training To Facilitate A Psychedelic Therapy Is Free – Check Out Cybin’s New Offer
Cybin Inc. (NYSE: CYBN), a clinical-stage biopharma company developing innovative psychedelic-based treatment options, is launching a free online facilitation training course.
Joint Venture Partnership Expands Access To Psychedelics Therapy For Some 50K Patients
Ketamine clinics operator Revitalist Lifestyle & Wellness Ltd. (OTCQB: RVLWF) and psilocybin bioscience and wellness platforms company Wake Network have partnered with GCM Partners LLC to offer new ketamine treatment locations in two facilities in Chicago, two in Orlando and one in Miami.
Check Out The Canadian Company Building On Several Vertical Psychedelics Businesses
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF)’s new clinic licensing model, The Numinus Network offers independent practitioners the chance to own and operate their own clinic under the Numinus brand through a licensing and services arrangement.
FSD Pharma To Spin Out New Publicly Trading Subsidiary As Distribution To Shareholders
Psychedelics biotech company FSD Pharma Inc.
Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More
MDMA Therapy For PTSD Nearing Legalization In U.S. And Worldwide, MAPS Releases Promising Data
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
MDXX-class molecules producer PharmAla Biotech Holdings Inc.
Psyched: Canada’s Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
Psychotherapists at the Massachusetts General Hospital (MGH) have undergone training by lead business Fluence toward participating in Tryp Therapeutics (OTCQB: T
How To Finance A Psychedelics Business? Learn From These Four Companies
Clearmind Medicine Announces Pricing of $3.5 Million Public Offering